Recursion Pharmaceuticals, Inc. RXRX Total Revenue
Total Revenue at other companies
Segments
Other financials
Where this comes from
Reported directly by Recursion Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Recursion Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Recursion Pharmaceuticals, Inc.'s total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Recursion Pharmaceuticals, Inc.'s total revenue?
- Recursion Pharmaceuticals, Inc. (RXRX) reported total revenue of $6.47M in Q1 2026.
- How has Recursion Pharmaceuticals, Inc.'s total revenue changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s total revenue decreased by 56.1% year-over-year, from $14.75M to $6.47M.
- What is the long-term trend for Recursion Pharmaceuticals, Inc.'s total revenue?
- Over 4 years (2021 to 2025), Recursion Pharmaceuticals, Inc.'s total revenue has grown at a 64.6% compound annual growth rate (CAGR), from $10.18M to $74.68M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.